Improving Chimeric Antigen Receptor Design and Therapy for Treatment of Cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Düsseldorf, Heinrich-Heine-Universität, Dissertation, 2024
- Schlagwort
-
Krebs
Therapie
Immuntherapie
- Ereignis
-
Veröffentlichung
- (wo)
-
Düsseldorf
- (wer)
-
Universitäts- und Landesbibliothek der Heinrich-Heine-Universität Düsseldorf
- (wann)
-
2024
- Urheber
- Beteiligte Personen und Organisationen
-
Hanenberg, Helmut
Kassack, Matthias
- URN
-
urn:nbn:de:hbz:061-20240603-111159-4
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:49 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bister, Arthur
- Hanenberg, Helmut
- Kassack, Matthias
- Universitäts- und Landesbibliothek der Heinrich-Heine-Universität Düsseldorf
Entstanden
- 2024
Ähnliche Objekte (12)
Optimization of chimeric antigen receptor (CAR) therapy
Chimeric antigen receptor T cell therapy to target lymphoid neoplasms
Improvement of chimeric antigen receptor T cell therapy for patients with hematological malignancies
Chimeric Antigen Receptor T Cell Research For Clinical Applications
Chimeric antigen receptor T cells for acute myeloid leukemia
Approaches to improve outcome of hepatitis B virus-specific chimeric antigen receptor T-cell therapy
Two cases of pancytopenia with Coombs-negative hemolytic anemia after chimeric antigen receptor T-cell therapy
Chimeric antigen receptor-redirected regulatory T cells as a therapy for multiple sclerosis and other neurological diseases
Investigations on polysialic acid as a potential tumor-specific target for chimeric antigen receptor T cell therapy
Tumor-Specific Reactive Oxygen Species Accelerators Improve Chimeric Antigen Receptor T Cell Therapy in B Cell Malignancies
Tumor-specific reactive oxygen species accelerators for improved chimeric antigen receptor (CAR) T cell therapy in B cell malignancies
Development of a CD22-specific chimeric antigen receptor (CAR) for the adoptive T cell therapy of leukemia and lymphoma
Optimization of chimeric antigen receptor (CAR) therapy
Chimeric antigen receptor T cell therapy to target lymphoid neoplasms
Improvement of chimeric antigen receptor T cell therapy for patients with hematological malignancies
Chimeric Antigen Receptor T Cell Research For Clinical Applications
Chimeric antigen receptor T cells for acute myeloid leukemia
Approaches to improve outcome of hepatitis B virus-specific chimeric antigen receptor T-cell therapy
Two cases of pancytopenia with Coombs-negative hemolytic anemia after chimeric antigen receptor T-cell therapy
Chimeric antigen receptor-redirected regulatory T cells as a therapy for multiple sclerosis and other neurological diseases
Investigations on polysialic acid as a potential tumor-specific target for chimeric antigen receptor T cell therapy
Tumor-Specific Reactive Oxygen Species Accelerators Improve Chimeric Antigen Receptor T Cell Therapy in B Cell Malignancies
Tumor-specific reactive oxygen species accelerators for improved chimeric antigen receptor (CAR) T cell therapy in B cell malignancies
Development of a CD22-specific chimeric antigen receptor (CAR) for the adoptive T cell therapy of leukemia and lymphoma
Optimization of chimeric antigen receptor (CAR) therapy
Chimeric antigen receptor T cell therapy to target lymphoid neoplasms
Improvement of chimeric antigen receptor T cell therapy for patients with hematological malignancies
Chimeric Antigen Receptor T Cell Research For Clinical Applications
Chimeric antigen receptor T cells for acute myeloid leukemia
Approaches to improve outcome of hepatitis B virus-specific chimeric antigen receptor T-cell therapy
Two cases of pancytopenia with Coombs-negative hemolytic anemia after chimeric antigen receptor T-cell therapy
Chimeric antigen receptor-redirected regulatory T cells as a therapy for multiple sclerosis and other neurological diseases
Investigations on polysialic acid as a potential tumor-specific target for chimeric antigen receptor T cell therapy
Tumor-Specific Reactive Oxygen Species Accelerators Improve Chimeric Antigen Receptor T Cell Therapy in B Cell Malignancies
Tumor-specific reactive oxygen species accelerators for improved chimeric antigen receptor (CAR) T cell therapy in B cell malignancies